Scholar Rock Holding (SRRK) Restructuring Costs (2024 - 2026)
Scholar Rock Holding's quarterly Restructuring Costs came in at $16.1 million in Q1 2026, up 80.41% year-on-year from $8.9 million in Q1 2025, and up 26.48% quarter-over-quarter from $12.8 million in Q4 2025.
Scholar Rock Holding has reported Restructuring Costs for 3 years, with the latest figure at $16.1 million in Q1 2026.
- For the quarter ending Q1 2026, Restructuring Costs rose 80.41% year-over-year to $16.1 million; the trailing twelve-month figure through Mar 2026 stood at $63.3 million (up 140.35% YoY), and the FY2025 full-year result was $56.1 million, up 150.55% from the prior year.
- Restructuring Costs for Q1 2026 stood at $16.1 million, up from $12.8 million in the prior quarter.
- The five-year high for Restructuring Costs was $19.4 million in Q3 2025, with the low at $5.0 million in Q1 2024.
- Average Restructuring Costs over 3 years is $10.5 million, with a median of $8.9 million recorded in 2025.
- Peak annual rise in Restructuring Costs reached 281.56% in 2025, while the deepest fall reached 78.8% in 2025.
- Tracing SRRK's Restructuring Costs over 3 years: stood at $6.2 million in 2024, then soared by 106.96% to $12.8 million in 2025, then increased by 26.48% to $16.1 million in 2026.
- The last three Restructuring Costs figures came in at $16.1 million (Q1 2026), $12.8 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.13 Mn |
| Dec 31, 2025 | 12.76 Mn |
| Sep 30, 2025 | 19.43 Mn |
| Jun 30, 2025 | 14.95 Mn |
| Mar 31, 2025 | 8.94 Mn |
| Dec 31, 2024 | 6.16 Mn |
| Sep 30, 2024 | 5.09 Mn |
| Jun 30, 2024 | 6.13 Mn |
| Mar 31, 2024 | 5.00 Mn |